HIV/AIDS information
Tags: HIV infections -- Treatment; AIDS (Disease) -- Treatment
Related Articles
- Hyperthermia trial expands. // AIDS Patient Care & STDs;Jun96, Vol. 10 Issue 3, p191
Details the US Food and Drug Administration's approval on the expansion of studies of whole-body extracorporeal hyperthermia utilizing the BioLogic-HT System for treatment of HIV/AIDS. Artificial induction of fever; Heat sensitivity of HIV.
- In the news. // AIDS Patient Care & STDs;Aug96, Vol. 10 Issue 4, p207
Presents updates on prevention and treatment of AIDS and HIV as of August 1996. Approval of the US Food and Drug Administration (FDA) to market Amplicor HIV-1 monitor test; New role for CC-CKR5; Viral load to predict HIV disease progression; Link between the treatment of other STDs and...
- Hyperthermia studies begin. // AIDS Patient Care & STDs;Oct96, Vol. 10 Issue 5, p314
Reports on the start of the Food and Drug Administration-approved studies of whole body extracorporeal hyperthermia (WBHT) using BioLogic-HT System in the treatment for AIDS and HIV infection. Artificial induction of fever by heating blood to affect HIV as method; Increased therapy time in the...
- Drug news and trial developments. // AIDS Patient Care & STDs;Mar1998, Vol. 12 Issue 3, p231
Presents information on drugs and trial developments in the treatment of human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS). AIDS vaccine study by VaxGen Incorporated; Study of HIV-positive patients receiving thalidomide treatment; Approval of rituximab for...
- List of pre-qualified products - 20 March 2002. // WHO Drug Information;2002, Vol. 16 Issue 1, p33
Presents pre-qualified pharmaceutical products for the Pilot Procurement Project, submitted by manufacturers of drugs for the treatment of HIV infection and AIDS.
- Fourth AIDS drug approved. // FDA Consumer;Sep94, Vol. 28 Issue 7, p2
Informs that a fourth drug has been granted Food and Drug Administration (FDA) approval for the treatment of HIV and AIDS. Treatment of adults with advanced HIV infection who no longer respond to other anti-viral drugs; Zerit (stavudine, also known as D4T).
- PHS proposes `parallel track' for new AIDS drugs. // Public Health Reports;Sep/Oct90, Vol. 105 Issue 5, p541
Reports on the US Public Health Service's (PHS) proposal for speeding the availability of investigational new drugs for AIDS and HIV-related diseases by means of a parallel track mechanism. Selection of patients with life-threatening illnesses including AIDS; Views on the safeguards to parallel...
- MCOs, AIDS activists join forces on national database for disease-management strategies. // Managed Healthcare;Apr98, Vol. 8 Issue 4, p7
Reports on the HIV Treatment Data Project, a national database on HIV/AIDS treatments and disease-management being planned by the managed care industry and AIDS activists. Collaboration of the Group Health Cooperative Center for Health Studies and the University of Washington's Center for AIDS...
- Protease inhibitor-sparing regimen suppresses HIV. // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p940
Details findings of a study presented at ICAAC which suggests that a simplified regimen requiring few pills is an effective first-line treatment for HIV/AIDS. Drugs included in the treatment; Similarity of the results with those achieved with protease inhibitors; Mean viral load reduction from...
- TRIAL BEGINS FOR RAIN FOREST AGENT. // AIDS Patient Care & STDs;Jan1999, Vol. 13 Issue 1, p59
Reports on the start of the phase 1B clinical trial for (+)-calanotide A, an anti-AIDS compound discovered in the rain forest of Sarawak, Malaysia. Assessment of safety and pharmocokinetics; Results of the phase 1A trial.
